Quantcast

Latest Amides Stories

2013-12-10 23:19:39

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - China Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked...

2013-12-10 23:04:36

Reportbuyer.com just published a new market research report: PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022. London (PRWEB) December 10, 2013 PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Type 2 Diabetes - UK Drug Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a...

2013-12-05 23:48:03

No data on patients with metformin intolerance or contraindication The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults with type 2 diabetes mellitus. It is an option when drug treatment is needed, but the drug metformin is not tolerated or cannot be used. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency...

2013-12-04 23:01:51

Bernstein Liebhard LLP is evaluating Pradaxa lawsuits on behalf of patients who suffered life-threatening internal bleeding, allegedly due to their use of the blood thinner. New York, New York (PRWEB) December 04, 2013 As nearly 2,000 Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) alleging injuries due to internal bleeding continue to move forward in federal court, Bernstein Liebhard LLP notes that Boehringer Ingelheim Pharmaceuticals, the manufacturer of the blood-thinner, has...

2013-12-02 23:01:23

Pradaxa Lawsuits Pending in Federal Litigation Allege the Maker of the Blood Thinner Failed to Provide Adequate Warnings Regarding Pradaxa Bleeding Side Effects, Lack of Antidote to Reverse Hemorrhaging from The Drug. Colubus, OH (PRWEB) December 02, 2013 The products liability litigation surrounding Pradaxa continues to grow, as Wright & Schulte LLC notes that the number of Pradaxa lawsuits pending in a federal multidistrict litigation underway in U.S. District Court, Southern...

2013-11-30 23:20:38

A Diovan Discount Card is free and easy to use. New York, NY (PRWEB) November 30, 2013 According to the CDC, roughly 1 in 3 Americans—about 31%—suffers from high blood pressure. This is serious news; high blood pressure can lead to heart disease or heart failure, stoke, cardiac arrest, or kidney disease, if left untreated. It can also affect a person’s vision, stamina, immune response, and general productivity. Worse still, only about 67% of all routine medical checkups include a...

2013-11-28 23:21:18

Researchers say that treatment may be an effective reversal agent in life-threatening bleeding cases. Resource4thePeople national network of attorneys continue to offer consumers affected by allegations free consultations over compensation rights. San Diego, CA (PRWEB) November 28, 2013 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople announced today its latest consumer update over allegations that the popular blood thinner Pradaxa (dabigatran)...

2013-11-27 23:30:00

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Dallas, TX (PRWEB) November 27, 2013 The DrugNews.net prescription drug safety center is announcing updated information on the site for patients taking the blood thinner Pradaxa. New court records show the number of lawsuits alleging internal bleeding injury or death from the drug have grown 6% in November*. DrugNews is a resource...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.